Article History
First Online: 11 November 2021
Competing interests
: S.E.L. is on the events adjudication committee for CVRx. S.E.L. provides consultation and is on the patient selection committee for Axon Therapeutics. R.J.T. reports general disclosures to include consulting relationships with Medtronic, Abbott, Aria CV Inc., Acceleron, Itamar, Edwards LifeSciences, Eidos Therapeutics, Lexicon Pharmaceuticals, Gradient, CareDx and United Therapeutics. R.J.T. is on a steering committee for Acceleron and Abbott, as well as a research advisory board for Abiomed. R.J.T. also does hemodynamic core lab work for Actelion and Merck. S.F. declares no competing interests.